Cell Signaling and Signal Transduction Vocabulary
Introduction to Cell Signaling and Basic Elements
Communication between Cells: Cell signaling and signal transduction represent the processes by which cells communicate and interpret messages to coordinate biological functions.
The Basic Elements of a Cell Signaling System: * Extracellular Messenger Molecules: These are the primary signals transmitted between cells. * Autocrine Signaling: The signaling cell possesses receptors on its own surface that respond to the messenger it produces, effectively communicating with itself. * Paracrine Signaling: Messenger molecules travel relatively short distances through the extracellular space to reach neighboring cells. * Endocrine Signaling: Messenger molecules (hormones) enter the bloodstream to reach distant target cells throughout the body.
Receptors and Ligands: * Target Cells: These cells possess receptors (on the surface or internally) that receive the extracellular message. * Ligand: A specific molecule that binds to a receptor. * Recruitment: Signaling often involves cytoplasmic protein recruitment to the activated receptor.
Signal Transduction Pathways: * Protein Cascades: Signaling pathways consist of a series of proteins that alter the conformation of the next protein in the sequence. * Signal Transduction: The overall process of converting an extracellular signal into an intracellular response. * Phosphorylation and Dephosphorylation: The primary mechanism for altering protein conformation and activity. * Kinases: Enzymes that add phosphate groups to proteins. * Phosphatases: Enzymes that remove phosphate groups. * Functional Changes via Phosphorylation: * Activating or inactivating an enzyme. * Increasing or decreasing protein-protein interactions. * Changing the subcellular location of a protein. * Triggering protein degradation. * Target Proteins: These are the ultimate recipients of the message that change cell activity.
Chemical Nature of Extracellular Messengers and Receptors
Classes of Extracellular Messengers: * Small Molecules: Includes amino acids and their derivatives. Examples: acetylcholine, epinephrine, dopamine, glutamate, and -aminobutyric acid (GABA). * Gases: Signaling molecules like Nitric Oxide () and Carbon Monoxide (). * Steroids: Derived from cholesterol. Examples include: * Estradiol (an estrogen). * Progesterone. * Testosterone. * Cortisol (a glucocorticoid). * Eicosanoids: Molecules derived from arachidonic acid. * Peptides and Proteins: For example, Insulin or Epidermal Growth Factor (EGF). * Other Related Molecules: Thyroid hormone, Vitamin , Retinoic acid, and Indole-3-acetic acid (an auxin plant hormone).
Receptor Types: * G-protein coupled receptors (GPCRs). * Receptor protein-tyrosine kinases (RTKs). * Ligand-gated channels. * Steroid hormone receptors.
Glucocorticoid Action Example: * Glucocorticoids cross the plasma membrane and bind to an inactive receptor bound to in the cytosol. * Binding releases , and the receptors dimerize. * The receptor dimer enters the nucleus, binds DNA, recruits coactivators and Histone Acetyltransferase (HAT), leading to the acetylation of nucleosomes and initiation of transcription.
Signal Transduction by G Protein-Coupled Receptors (GPCRs)
GPCR Characteristics: * Largest superfamily of proteins encoded by animal genomes (thousands of members). * Contain seven -helical transmembrane domains. * Interact with heterotrimeric G proteins.
Natural Ligands for GPCRs: * Hormones (animal and plant). * Neurotransmitters. * Opium derivatives. * Chemoattractants (odorants, tastants, and photons).
Physiological Examples of GPCR-Mediated Processes: * Epinephrine: Binds -Adrenergic receptor activates Adenylyl cyclase Glycogen breakdown. * Serotonin: Binds Serotonin receptor activates Adenylyl cyclase Behavioral sensitization/learning in Aplysia. * Light: Binds Rhodopsin activates phosphodiesterase Visual excitation. * IgE-antigen complexes: Binds Mast cell IgE receptor activates Phospholipase C Secretion. * f-Met peptide: Binds Chemotactic receptor activates Phospholipase C Chemotactic response. * Acetylcholine: Binds Muscarinic receptor opens Potassium channel Slowing of pacemaker activity.
Mechanism of GPCR Activation: 1. Ligand binds to the extracellular domain, inducing a conformational change. 2. GDP is exchanged for GTP on the subunit of the heterotrimeric G protein. 3. dissociates from the complex and activates an effector (e.g., adenylyl cyclase). 4. The effector produces a second messenger (e.g., ).
G Protein Families: * : Couples receptors to adenylyl cyclase stimulation. * : Contains subunits that activate . * : Inhibits adenylyl cyclase. * : Less well characterized.
The G Protein Cycle and Termination: * Activity is terminated by the hydrolysis of GTP to GDP and by the subunit's intrinsic GTPase activity. * RGS proteins (Regulators of G protein Signaling) stimulate this hydrolysis. * Inactive GDP-bound reassociates with the complex. * Arrestins: Binding of arrestin to a phosphorylated GPCR competes with G protein binding, leading to desensitization. * Recycling: GPCRs can be internalized; if returned to the surface, the cell is "resensitized."
Second Messengers: Cyclic AMP (cAMP) and Bacterial Toxins
Cyclic AMP (): * Synthesized from ATP by Adenylyl cyclase. * Degraded into AMP by phosphodiesterase. * Enables large-scale coordinated responses from a single extracellular signal.
Bacterial Toxins Targeting Signaling: * Cholera Toxin: Modifies to keep adenylyl cyclase active by inhibiting GTPase activity, leading to massive intestinal water loss. * Pertussis Toxin: Inactivates subunits, resulting in immune defense inhibition (whooping cough).
cAMP-Induced Glucose Mobilization: * Triggered by Epinephrine or Glucagon. * Adenylyl cyclase produces , which activates Protein Kinase A (PKA). * PKA phosphorylates Phosphorylase kinase, which then activates Glycogen phosphorylase. * Glycogen phosphorylase breaks down glycogen into Glucose-1-phosphate. * Inhibition: PKA also phosphorylates Glycogen synthase, inactivating it to prevent concurrent glycogen storage.
cAMP in Gene Expression: * Activated PKA translocates to the nucleus. * PKA phosphorylates CREB (cAMP Response Element-Binding protein). * Phosphorylated CREB dimerizes and binds to CRE (cAMP Response Element) on DNA to initiate transcription of genes like those for gluconeogenesis.
Phosphatidylinositol-Derived Second Messengers and Ca2+ Signaling
Phospholipid Signaling Molecules: * Membrane phospholipids are converted to messengers by phospholipases, kinases, and phosphatases. * (Phospholipase C-): Splits into two second messengers: 1. Diacylglycerol (DAG): Remains in the membrane; recruits and activates Protein Kinase C (PKC). Phorbol esters mimic DAG and can cause malignant cell behavior. 2. Inositol 1,4,5-trisphosphate (): Diffuses into the cytosol; binds to receptors (tetrameric channels) on the Smooth ER.
Calcium () as a Messenger: * Normal cytosolic levels are kept extremely low by active pumps. * binding opens ER channels, releasing into the cytoplasm. * Bursts of release cause oscillations; triggered by stimuli like Vasopressin in the liver. * Calmodulin: The best-studied calcium-binding protein; has 4 binding sites. When bound to , it undergoes a conformational change to activate effectors like CaM kinase II or MLCK. * Other Ca-activated proteins: Troponin C (muscle), Calpain (protease), -actinin.
Cellular Responses to IP3: Contraction in smooth muscle, actin polymerization in slime molds, shape change in blood platelets, and membrane depolarization in sea urchin eggs.
Receptor Protein-Tyrosine Kinases (RTKs) and the Ras-MAPK Pathway
Receptor Protein-Tyrosine Kinases (RTKs): * Activated by growth factors (PDGF, EGF) and differentiation factors. * Activation Mechanism: 1. Ligand-mediated dimerization (e.g., PDGF) or Receptor-mediated dimerization (e.g., EGF). 2. Trans-autophosphorylation: Kinase domains phosphorylate each other on tyrosine residues. 3. The activation loop moves away from the substrate-binding site, activating the kinase.
Downstream Signaling: * Phosphotyrosine residues serve as binding sites for proteins with SH2 (Src-homology 2) or PTB (Phosphotyrosine-binding) domains. * Adaptor Proteins: e.g., Grb2, which contains one SH2 and two SH3 domains (SH3 binds proline-rich regions).
The Ras-MAP Kinase Pathway: * Ras: A small monomeric G protein (GTPase) anchored to the plasma membrane. * Active state: Ras-GTP; Inactive state: Ras-GDP. * Accessory Proteins: * GEFs (Guanine nucleotide-exchange factors): Stimulate GDP-to-GTP exchange (activates Ras). Example: Sos. * GAPs (GTPase-activating proteins): Stimulate GTP hydrolysis (inactivates Ras). * GDIs (Guanine nucleotide-dissociation inhibitors): Inhibit GDP release. * MAPK Cascade: Ras activates Raf (MAPKKK) Raf activates MEK (MAPKK) MEK activates ERK (MAPK) ERK phosphorylates transcription factors.
Scaffolding Proteins: Tether pathway members together to ensure specificity and enhance interaction efficiency (e.g., , , yeast ).
Insulin Receptor Signaling and Glucose Homeostasis
Insulin Receptor Structure: A dimer consisting of and chains.
Mechanism: 1. Insulin binds RTK autophosphorylation. 2. Activation of IRS-1 and IRS-2 (Insulin Receptor Substrates). 3. PI 3-kinase (PI3K) binds IRS via SH2 domains and converts membrane lipids into . 4. recruits PKB (Protein Kinase B) and PDK1.
Regulation of Glucose Transport: * Recruitment of GLUT4 transporters from intracellular vesicles (tethered by TUG protein) to the plasma membrane. * Inhibition of GSK-3 kinase leads to an increase in Glycogen synthase activity, promoting glucose storage.
Sensory Perception and NO Signaling
GPCRs in Sensory Systems: * Vision: Rhodopsin (black-and-white) and color receptors in cones are GPCRs. * Smell: Nasal epithelium contains over 400 types of odorant GPCRs. * Taste: Receptors detect five basic qualities: salty, sour, sweet, bitter, and savory (umami).
Nitric Oxide (NO) as a Messenger: * Produced by Nitric oxide synthase. * Mechanism: diffuses to smooth muscle cells and activates Guanylyl cyclase to produce . * leads to smooth muscle relaxation and blood vessel dilation. * Nitroglycerine: Used to treat angina because it is metabolized into , increasing heart blood flow. * Viagra (Sildenafil): Inhibits phosphodiesterase 5 (PDE5). This prevents the breakdown of , maintaining blood vessel dilation for male arousal. It does not inhibit PDE3 (vital for heart muscle contraction).